29 December 2023
Ropes & Gray Represents LianBio in Licensing Agreement with Janssen Pharmaceuticals in China and Other Asian Markets
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Hannah England Lead | Ropes & Gray | Partner | life sciences licensing | Not stated |
| Zach Blume | Ropes & Gray | Partner | emerging companies and venture capital | Not stated |
| Elaine Murphy | Ropes & Gray | Partner | tax | Not stated |
| Michael Mendel | Ropes & Gray | Counsel | tax | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 25m ($25 million)
- What the figure measures
- Total transaction value
- Client
- LianBioSell-side
- Counterparties
- Janssen Pharmaceuticals (Buy-side)